Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.57 |
| ▸ | TP53 | P04637 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | CDC25B | P30305 | 1/20 | 0.57 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.57 |
| ▸ | ATM | Q13315 | 1/20 | 0.57 |
| ▸ | AHR | P35869 | 2/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.55 |
| ▸ | PIM1 | P11309 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | NR4A2 | P43354 | 3/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29489280 | 1.00 | GPR84 (0.77) | GPR84ALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL2028344 | 0.88 | GPR84 (1.00) | GPR84ALDH1A1KMT2AMEN1MAPK1 | |
| SCHEMBL9640753 | 0.87 | CDC25B (0.57) | GPR84ALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL6327424 | 0.86 | GPR84 (0.60) | GPR84ALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL11984941 | 0.85 | GPR84 (0.55) | GPR84ALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL29808478 | 0.84 | F7 (0.60) | GPR84KMT2AMEN1MAPTCDC25B | |
| SCHEMBL15558983 | 0.84 | GPR84 (0.54) | GPR84ALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL22955917 | 0.84 | GPR84 (0.54) | GPR84ALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL14111893 | 0.83 | CDC25B (0.54) | GPR84ALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL6402031 | 0.83 | SMN1; SMN2 (0.63) | GPR84KMT2AMEN1MAPTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10175258-B2 | Detection of synthetic cannabinoids | RANDOX LABORATORIES LIMITED (GB) | 2019-01-08 | — | — | US | claimed |
| CN-104402992-B | A kind of synthetic method synthesizing hemp antigen and the application for synthesizing hemp antigen | 杭州安旭科技有限公司 | 2018-09-18 | — | — | CN | claimed |
| US-20150118763-A1 | DETECTION OF SYNTHETIC CANNABINOIDS | RANDOX LABORATORIES LIMITED (GB) | 2015-04-30 | — | — | US | claimed |
| CN-104402992-A | Synthetic method for synthesizing cannabis sativa antigen and application of synthesized cannabis sativa antigen | HANGZHOU ASSURE TECHNOLOGY CO LTD | 2015-03-11 | — | — | CN | claimed |
| EP-2487155-B1 | Detection of Synthetic Cannabinoids | RANDOX LAB LTD (GB) | 2015-01-21 | — | — | EP | claimed |
| US-8906633-B2 | Detection of synthetic cannabinoids | RANDOX LABORATORIES LIMITED (GB) | 2014-12-09 | — | — | US | claimed |
| CN-102838525-A | Synthesis method of 1-amyl-3-(1naphthoyl) indole | JIANGSU HAOHUA FINE CHEMICAL CO LTD | 2012-12-26 | — | — | CN | claimed |
| US-20120208213-A1 | Detection of Synthetic Cannabinoids | RANDOX LABORATORIES LIMITED (GB) | 2012-08-16 | — | — | US | claimed |
| EP-2487155-A1 | Detection of Synthetic Cannabinoids | Randox Laboratories Ltd. (GB) | 2012-08-15 | — | — | EP | claimed |
| US-20250195409-A1 | METHODS FOR IMPROVING CUTANEOUS PERMEATION OF CANNABINOIDS AND FATTY ACID AMIDES | Ananda Scientific, Inc. (US) | 2025-06-19 | — | — | US | disclosed |
| EP-4110325-A1 | TRANSDERMAL AND/OR TOPICAL PHARMACEUTICAL FORMULATIONS COMPRISING CANNABIDIOL AND/OR TETRAHYDROCANNABINOL FOR THE TREATMENT OF CHRONIC PAIN | Pike Therapeutics, Inc. (CA) | 2023-01-04 | — | — | EP | disclosed |
| WO-2022217147-A1 | METHODS FOR IMPROVING CUTANEOUS PERMEATION OF CANNABINOIDS AND FATTY ACID AMIDES | ROSENFELD MARK J (US) | 2022-10-13 | — | — | WO | disclosed |
| EP-3958856-A1 | COMPOSITIONS AND METHODS FOR USE OF CANNABINOIDS FOR NEUROPROTECTION | Inmed Pharmaceuticals Inc. (CA) | 2022-03-02 | — | — | EP | disclosed |
| US-10968206-B2 | Cannabinergic nitrate esters and related analogs | NORTHEASTERN UNIVERSITY (US) | 2021-04-06 | — | — | US | disclosed |
| EP-2487155-A1 | Detection of Synthetic Cannabinoids | Randox Laboratories Ltd. (GB) | 2012-08-15 | — | — | EP | disclosed |
| US-5817651-A | ANALGESICS, RHEUMATIC DISEASES, ANTIINFLAMMATORY AGENTS | SANOFI (FR) | 1998-10-06 | — | — | US | disclosed |
| US-5607933-A | METHODS FOR TREATMENT OF GLAUCOMA AND FOR RELIEF OF PAIN AND RHEUMATIC AND INFLAMMATORY CONDITIONS BY ADMINISTERING THE INDOLES; N-HETERYL IS 2-PIPERAZINYL | STERLING WINTHROP INC. (US) | 1997-03-04 | — | — | US | disclosed |
| US-5324737-A | Analgesics, antirheumatic and antiinflammatory agents, glaucoma | STERLING WINTHROP INC. (US) | 1994-06-28 | — | — | US | disclosed |
| US-5068234-A | Analgesics, rheumatic diseases, antiinflammatory agents or antiglaucoma | STERLING DRUG INC. (US) | 1991-11-26 | — | — | US | disclosed |
| EP-0444451-A2 | 3-Arylcarbonyl-1H-indoles useful as therapeutic agents | STERLING WINTHROP INC. (US) | 1991-09-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150118763-A1 | DETECTION OF SYNTHETIC CANNABINOIDS | CNR2, CNR1, FAAH | GPR84 64/4885ALDH1A1 4246/4885KMT2A 2187/4885 |
| US-10968206-B2 | Cannabinergic nitrate esters and related analogs | CNR2, CNR1, CHRNB3 | GPR84 315/4885ALDH1A1 1850/4885KMT2A 4178/4885 |
| US-20250195409-A1 | METHODS FOR IMPROVING CUTANEOUS PERMEATION OF CANNABINOIDS AND FATTY ACID AMIDES | CNR2, CNR1, FAAH | GPR84 106/4885ALDH1A1 1320/4885KMT2A 2718/4885 |
| US-20120208213-A1 | Detection of Synthetic Cannabinoids | CNR2, CNR1, FAAH | GPR84 64/4885ALDH1A1 4246/4885KMT2A 2187/4885 |
| US-10175258-B2 | Detection of synthetic cannabinoids | CNR2, CNR1, FAAH | GPR84 64/4885ALDH1A1 4246/4885KMT2A 2187/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.